DOPA decarboxylase inhibitor (benserazide)
GPTKB entity
Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
benserazide
|
| gptkbp:administeredBy |
gptkb:levodopa
|
| gptkbp:ATCCode |
N04BA02
|
| gptkbp:contraindication |
narrow-angle glaucoma
severe liver disease |
| https://www.w3.org/2000/01/rdf-schema#label |
DOPA decarboxylase inhibitor (benserazide)
|
| gptkbp:increasesCNSAvailabilityOf |
gptkb:levodopa
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits DOPA decarboxylase
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:reducesPeripheralMetabolismOf |
gptkb:levodopa
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
hypotension dyskinesia |
| gptkbp:usedFor |
gptkb:Parkinson's_disease
|
| gptkbp:bfsParent |
gptkb:Madopar
|
| gptkbp:bfsLayer |
7
|